CatalystPit

BBIOBridgeBio Pharma, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $65.80 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$12.86B
RECENT INSIDER TRADES
  • 2026-09-21 · Kumar Neil (Chief Executive Officer) · SELL
  • 2026-08-20 · Kumar Neil (Chief Executive Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders513
Shares held301,975,245
Value$16.88B
Percent of shares outstanding154.47%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-05-11 · Gilbert Cisneros · BUY · $1,001 - $15,000
RECENT NEWS
  • BridgeBio to present acoramidis data at HFSA meeting
  • BridgeBio to present Phase 3 CALIBRATE trial data for encaleret at ASBMR 2026
  • BridgeBio launches nationwide ATTR-CM education effort ahead of World Amyloidosis Day
  • William Blair reiterates Outperform on BridgeBio Pharma stock
  • Jefferies reiterates Buy on BridgeBio Pharma stock, $110 target
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
BridgeBio Pharma, Inc. (BBIO) · Stock Price, Insider Trades, Congress Trades · CatalystPit